高级检索
张楠, 黄孝学, 张子良, 罗玉, 林君谦, 王涛. 外源性乳酸对高脂饲料诱导肥胖小鼠的代谢调节作用[J]. 中国药科大学学报, 2023, 54(5): 614-625. DOI: 10.11665/j.issn.1000-5048.2023050501
引用本文: 张楠, 黄孝学, 张子良, 罗玉, 林君谦, 王涛. 外源性乳酸对高脂饲料诱导肥胖小鼠的代谢调节作用[J]. 中国药科大学学报, 2023, 54(5): 614-625. DOI: 10.11665/j.issn.1000-5048.2023050501
ZHANG Nan, HUANG Xiaoxue, ZHANG Ziliang, LUO Yu, LIN Junqian, WANG Tao. Metabolic regulation of exogenous lactate on obese mice induced by high fat diet[J]. Journal of China Pharmaceutical University, 2023, 54(5): 614-625. DOI: 10.11665/j.issn.1000-5048.2023050501
Citation: ZHANG Nan, HUANG Xiaoxue, ZHANG Ziliang, LUO Yu, LIN Junqian, WANG Tao. Metabolic regulation of exogenous lactate on obese mice induced by high fat diet[J]. Journal of China Pharmaceutical University, 2023, 54(5): 614-625. DOI: 10.11665/j.issn.1000-5048.2023050501

外源性乳酸对高脂饲料诱导肥胖小鼠的代谢调节作用

Metabolic regulation of exogenous lactate on obese mice induced by high fat diet

  • 摘要: 探讨外源性乳酸对高脂喂养诱导肥胖小鼠的代谢调节作用。采用脂肪含量60%的全合成高脂饲料建立C57小鼠代谢紊乱及肥胖模型,一部分小鼠采取高脂饲料喂养4周造模,于造模同时腹腔注射给予500 mg/(kg·d) 乳酸预防性干预4周;另一部分小鼠采取高脂饲料喂养8周造模,于造模4周后给予500 mg/(kg·d) 乳酸治疗4周。试验期间测定各组小鼠体重、摄食量变化,检测血清葡萄糖、乳酸、甘油三酯、胰岛素及肝糖原水平,通过口服糖耐量(OGTT)和胰岛素耐量(ITT)检测机体葡萄糖代谢和胰岛素抵抗情况,实验结束解剖取脂肪组织称重并进行脂肪组织病理学检查,通过RT-PCR检测脂肪组织的脂质合成和脂质分解基因表达情况。结果显示:(1)4周预防给药试验中,乳酸对正常(CON)和高脂饮食(HFD)小鼠体重未见明显影响,却可提高皮下脂肪与内脏脂肪的质量比;乳酸给药可明显降低HFD小鼠空腹血糖和肝糖原,同时升高血乳酸水平,对HFD小鼠糖耐量受损具有显著改善;乳酸可改善HFD组脂肪细胞的大小和排列形态,同时明显下调脂肪组织中脂肪酸合成和脂解基因表达。(2)在治疗8周实验中,乳酸两种给药途径均能部分减轻HFD组小鼠和减少摄食量,对于脂肪质量有部分改善趋势;乳酸两种给药途径均可明显降低HFD小鼠空腹血糖,显著改善糖耐量和胰岛素耐量,对空腹胰岛素水平及胰岛素抵抗指数也有部分改善作用;乳酸两种给药途径对肥胖小鼠脂肪细胞形态有不同程度的改善作用,同时显著下调脂肪组织中脂解基因表达。由此可见,对于高脂饲料诱导的肥胖性代谢失衡小鼠,给予外源性乳酸可以刺激糖代谢,抑制脂肪组织脂解,避免脂肪细胞肥大,进而改善糖耐量和胰岛素敏感性,减轻糖脂代谢紊乱。

     

    Abstract: This study investigates the metabolic regulatory effects of exogenous lactate on obesity mice induced by high-fat diet.We established obesity and metabolic disorder C57 mice model using a synthetic high-fat forage containing 60% fat.Some mice were fed with high-fat diet for 4 weeks to establish the model, being given 500 mg/(kg?d) lactate with ip for 4 weeks at the same time; the others were fed with high-fat diet for 8 weeks to establish the model, being given 500 mg/(kg?d) lactate 4 weeks after 4 weeks of modeling.During the trial period, the change of body weight and food intake, as well as serum glucose, lactate, triglycerides, insulin, and liver glycogen levels of both groups of mice were measured.Oral glucose tolerance test (OGTT) and insulin tolerance test (ITT) were used to assess glucose metabolism and insulin resistance in the body.At the end of the experiment, adipose tissue was dissected for weighing and histopathological examination.The expression of lipid synthesis and lipolysis genes in adipose tissue was detected by real-time PCR.The results showed that: (1) in the 4-week preventive medication trial, lactate had no significant effect on the body weight of normal and high-fat diet (HFD) mice, yet it increased the subcutaneous fat/visceral fat weight ratio; lactate could significantly reduce fasting blood glucose and liver glycogen levels in HFD mice while increasing blood lactate levels, significantly improving impaired glucose tolerance in HFD mice; lactate could improve the size and arrangement of adipocytes in the HFD group while significantly down-regulating the expression of fatty acid synthesis and lipolysis genes in adipose tissue; (2) in the 8-week treatment, both routes of lactate administration could partially reduce body weight in HFD group mice and reduce food intake, with the improvement trend for fat weight; both routes of lactate administration could significantly reduce fasting blood glucose levels in HFD mice, while significantly improving glucose and insulin tolerance, with some improvement of fasting insulin levels and insulin resistance index; both routes of lactate administration showed different degrees of improvement effect on adipocyte morphology in obese mice while significantly down-regulating lipolysis gene expression in adipose tissue.Therefore, for high-fat diet-induced obese mice with metabolic imbalance, exogenous lactate can stimulate glucose metabolism, inhibit adipose tissue lipolysis, and prevent adipocyte hypertrophy, thereby improving glucose tolerance and insulin sensitivity and reducing sugar-lipid metabolic disorder.

     

/

返回文章
返回